Anlotinib Not Yet Recruiting Phase N/A Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03769805Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC